SCHEMBL10148411

SCHEMBL10148411

FC(F)(F)c1cnc(S)c(C(F)(F)F)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
POLQ O75417 1/20 0.36
KDM4E B2RXH2 3/20 0.36
POLB P06746 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
PLAU P00749 1/20 0.36
AGBL2 Q5U5Z8 1/20 0.36
HTT P42858 2/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
TRPV4 Q9HBA0 1/20 0.34
CES2 O00748 1/20 0.34
GAA P10253 2/20 0.34
PKM P14618 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3464720 0.77 ALDH1A1 (0.53) ALDH1A1KDM4EPOLBSMN1; SMN2PLAU
SCHEMBL1668412 0.77 ALDH1A1 (0.42) ALDH1A1KDM4EPOLBSMN1; SMN2PLAU
SCHEMBL16404975 0.74 AGBL2 (0.43) ALDH1A1POLQKDM4EPOLBSMN1; SMN2
SCHEMBL3643010 0.74 ALDH1A1 (0.43) ALDH1A1POLQKDM4EPOLBSMN1; SMN2
SCHEMBL8408164 0.74 PIK3CD (0.50) ALDH1A1KDM4EPOLBSMN1; SMN2PLAU
SCHEMBL27229540 0.74 ALDH1A1 (0.42) ALDH1A1POLQKDM4EPOLBSMN1; SMN2
SCHEMBL25299377 0.70 ALDH1A1 (0.60) ALDH1A1POLBSMN1; SMN2HTTMAPT
SCHEMBL30517122 0.70 ALDH1A1 (0.60) ALDH1A1POLBSMN1; SMN2HTTMAPT
SCHEMBL15862919 0.70 KMT2A (0.49) ALDH1A1KDM4ESMN1; SMN2PLAUAGBL2
SCHEMBL1665443 0.70 ALDH1A1 (0.51) ALDH1A1KDM4EPOLBSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389546-B2 Compounds for modulating TRPV3 function HYDRA BIOSCIENCES, INC. (US) 2013-03-05 US disclosed
US-20120015979-A1 Compounds for Modulating TRPV3 Function Hydra Biosciences, Inc, (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015979-A1 Compounds for Modulating TRPV3 Function TRPV3, TRPV1, TRPV4 ALDH1A1 3074/4885POLQ 4852/4885KDM4E 3811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.